Traditional Chinese medicine formulae: A complementary method for the treatment of polycystic ovary syndrome

被引:7
作者
Fu, Li-Wen [1 ]
Gao, Zu [1 ]
Zhang, Ning [2 ]
Yang, Nan [1 ]
Long, Hui-Yan [1 ]
Kong, Ling-Yuan [1 ]
Li, Xiu-Yang [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250355, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Shandong Prov Hosp Tradit Chinese, Affiliated Hosp, Dept Reprod & Genet, Jinan 250000, Peoples R China
关键词
Polycystic ovary syndrome; Traditional Chinese Medicine formula; clinical application; Mechanism of action; Active ingredients; CITRUS-AURANTIUM L; SYNDROME PCOS; SERUM-LEVELS; DEFINITION; EXPRESSION; MECHANISM; SYMPTOMS; HONOKIOL; INJURY; WOMEN;
D O I
10.1016/j.jep.2023.117698
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance Polycystic ovary syndrome (PCOS) is a prevalent female endocrine condition that significantly affects women of all age groups and is characterized by metabolic dysfunction. The efficacy of existing pharmaceutical interventions for the treatment of PCOS remains inadequate. With a rich history and cultural significance spanning thousands of years, Traditional Chinese Medicine (TCM) is extensively employed for treating a variety of ailments and can serve as a supplementary therapy for managing PCOS. Multiple clinical observations and laboratory tests have unequivocally demonstrated the substantial effectiveness and safety of TCM formulae in treating PCOS, and further investigations are currently in progress.
引用
收藏
页数:15
相关论文
共 140 条
  • [1] Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
    Abraham Gnanadass, Subeka
    Divakar Prabhu, Yogamaya
    Valsala Gopalakrishnan, Abilash
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (03) : 631 - 643
  • [2] Serum levels of anti-histone and anti-double-strand DNA antibodies before and after laparoscopic ovarian drilling in women with polycystic ovarian syndrome
    Samsami D.A.
    Razmjoei P.
    Parsanezhad M.E.
    [J]. The Journal of Obstetrics and Gynecology of India, 2014, 64 (1) : 47 - 52
  • [3] Trait emotional intelligence and quality of life in women with polycystic ovary syndrome: Dysmorphic concerns and general distress as mediators
    Barberis, Nadia
    Calaresi, Danilo
    Cannavo, Marco
    Verrastro, Valeria
    [J]. COMPREHENSIVE PSYCHIATRY, 2023, 122
  • [4] Polycystic Ovary Syndrome: A Contemporary Clinical Approach
    Bjekic-Macut, Jelica
    Vukasin, Tamara
    Velija-Asimi, Zelija
    Burekovic, Azra
    Zdravkovic, Marija
    Andric, Zoran
    Brankovic, Marija
    Crevar-Marinovic, Slobodanka
    Madic, Tatjana
    Stanojlovic, Olivera
    Milutinovic, Danijela, V
    Livadas, Sarantis
    Mastorakos, George
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (36) : 3812 - 3820
  • [5] Characterization of DNA Methylation and Screening of Epigenetic Markers in Polycystic Ovary Syndrome
    Cao, Pengbo
    Yang, Wanting
    Wang, Peijun
    Li, Xihe
    Nashun, Buhe
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [6] Cao X.C., 2022, J. New Chin. Med., V54, P48, DOI [10.13457/j.cnki.jncm.2022.23.009, DOI 10.13457/J.CNKI.JNCM.2022.23.009]
  • [7] Chavez Guadalupe Nayeli, 2023, Int J Environ Res Public Health, V20, DOI 10.3390/ijerph20156534
  • [8] The role of MiRNA in polycystic ovary syndrome (PCOS)
    Chen, Baiqi
    Xu, Ping
    Wang, Jing
    Zhang, Chunping
    [J]. GENE, 2019, 706 : 91 - 96
  • [9] Chen C.X., 2003, Chin. Tradit. Herb. Drugs, P49, DOI [10.7501/j.issn.0253-2670.2003.9.437, DOI 10.7501/J.ISSN.0253-2670.2003.9.437]
  • [10] Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism
    Chen, Huize
    Deng, Chujun
    Meng, Zeyu
    Meng, Shengxi
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14